Literature DB >> 30594349

EMT Transition States during Tumor Progression and Metastasis.

Ievgenia Pastushenko1, Cédric Blanpain2.   

Abstract

Epithelial-mesenchymal transition (EMT) is a process in which epithelial cells acquire mesenchymal features. In cancer, EMT is associated with tumor initiation, invasion, metastasis, and resistance to therapy. Recently, it has been demonstrated that EMT is not a binary process, but occurs through distinct cellular states. Here, we review the recent studies that demonstrate the existence of these different EMT states in cancer and the mechanisms regulating their functions. We discuss the different functional characteristics, such as proliferation, propagation, plasticity, invasion, and metastasis associated with the distinct EMT states. We summarize the role of the transcriptional and epigenetic landscapes, gene regulatory network and their surrounding niche in controlling the transition through the different EMT states.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cancer; epithelial–mesenchymal transition; hybrid EMT; metastasis; plasticity; stemness

Year:  2018        PMID: 30594349     DOI: 10.1016/j.tcb.2018.12.001

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  592 in total

Review 1.  Multifaceted Roles of Long Non-coding RNAs in Head and Neck Cancer.

Authors:  Leslie Duncan; Chloe Shay; Yong Teng
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  TGFβ biology in cancer progression and immunotherapy.

Authors:  Rik Derynck; Shannon J Turley; Rosemary J Akhurst
Journal:  Nat Rev Clin Oncol       Date:  2020-07-24       Impact factor: 66.675

Review 3.  Cholangiocarcinoma 2020: the next horizon in mechanisms and management.

Authors:  Jesus M Banales; Jose J G Marin; Angela Lamarca; Pedro M Rodrigues; Shahid A Khan; Lewis R Roberts; Vincenzo Cardinale; Guido Carpino; Jesper B Andersen; Chiara Braconi; Diego F Calvisi; Maria J Perugorria; Luca Fabris; Luke Boulter; Rocio I R Macias; Eugenio Gaudio; Domenico Alvaro; Sergio A Gradilone; Mario Strazzabosco; Marco Marzioni; Cédric Coulouarn; Laura Fouassier; Chiara Raggi; Pietro Invernizzi; Joachim C Mertens; Anja Moncsek; Sumera Rizvi; Julie Heimbach; Bas Groot Koerkamp; Jordi Bruix; Alejandro Forner; John Bridgewater; Juan W Valle; Gregory J Gores
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-06-30       Impact factor: 46.802

Review 4.  Steps in metastasis: an updated review.

Authors:  Jamal Majidpoor; Keywan Mortezaee
Journal:  Med Oncol       Date:  2021-01-04       Impact factor: 3.064

5.  From Proteomic Mapping to Invasion-Metastasis-Cascade Systemic Biomarkering and Targeted Drugging of Mutant BRAF-Dependent Human Cutaneous Melanomagenesis.

Authors:  Aikaterini F Giannopoulou; Athanassios D Velentzas; Athanasios K Anagnostopoulos; Adamantia Agalou; Nikos C Papandreou; Stamatia A Katarachia; Dimitra G Koumoundourou; Eumorphia G Konstantakou; Vasiliki I Pantazopoulou; Anastasios Delis; Maria T Michailidi; Dimitrios Valakos; Dimitris Chatzopoulos; Popi Syntichaki; Vassiliki A Iconomidou; Ourania E Tsitsilonis; Issidora S Papassideri; Gerassimos E Voutsinas; Polydefkis Hatzopoulos; Dimitris Thanos; Dimitris Beis; Ema Anastasiadou; George Th Tsangaris; Dimitrios J Stravopodis
Journal:  Cancers (Basel)       Date:  2021-04-22       Impact factor: 6.639

6.  ZNF451 stabilizes TWIST2 through SUMOylation and promotes epithelial-mesenchymal transition.

Authors:  Wang Zeng; Shuchen Gu; Yi Yu; Yili Feng; Mu Xiao; Xin-Hua Feng
Journal:  Am J Cancer Res       Date:  2021-03-01       Impact factor: 6.166

7.  BRCA1-associated protein inhibits glioma cell proliferation and migration and glioma stem cell self-renewal via the TGF-β/PI3K/AKT/mTOR signalling pathway.

Authors:  Bo Wang; Chen Cao; Xi Liu; Xin He; Hao Zhuang; Dong Wang; Budong Chen
Journal:  Cell Oncol (Dordr)       Date:  2019-11-27       Impact factor: 6.730

8.  Mechanism of transmembrane and coiled-coil domain 1 in the regulation of proliferation and migration of A549 cells.

Authors:  Chen Yang; Yuan Wang; Jian-Qi Bai; Jing-Ru Zhang; Pei-Yan Hu; Yan Zhu; Qin Ouyang; Hong-Mei Su; Qiu-Yue Li; Ping Zhang
Journal:  Oncol Lett       Date:  2020-08-26       Impact factor: 2.967

9.  Single-Chromosomal Gains Can Function as Metastasis Suppressors and Promoters in Colon Cancer.

Authors:  Anand Vasudevan; Prasamit S Baruah; Joan C Smith; Zihua Wang; Nicole M Sayles; Peter Andrews; Jude Kendall; Justin Leu; Narendra Kumar Chunduri; Dan Levy; Michael Wigler; Zuzana Storchová; Jason M Sheltzer
Journal:  Dev Cell       Date:  2020-02-24       Impact factor: 12.270

10.  UCHL3 promotes proliferation of colorectal cancer cells by regulating SOX12 via AKT/mTOR signaling pathway.

Authors:  Jiangning Li; Yang Zheng; Xiaofeng Li; Xue Dong; Weiyan Chen; Zhongying Guan; Chong Zhang
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.